Targeting lipid biosynthesis pathways for hepatitis B virus cure

Targeting lipid biosynthesis pathways for hepatitis B virus cure

Show other versions (1)

Chronic hepatitis B virus (HBV) infection is characterized by the presence of high circulating levels of non-infectious lipoprotein-like HBV surface antigen (HBsAg) particles thought to contribute to chronic immune dysfunction in patients. Lipid and metabolomic analysis of humanized livers from immu...

Full description

Bibliographic Details
Main Authors: Anastasia Hyrina, Dara Burdette, Zhijuan Song, Ricardo Ramirez, Ayse Okesli-Armlovich, Archana Vijayakumar, Jamie Bates, James L. Trevaskis, Simon P. Fletcher, William A. Lee, Meghan M. Holdorf
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352027/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352027/?tool=EBI

Similar Items